Cohance Lifesciences Limited (BOM:543064)
India · Delayed Price · Currency is INR 425.05
-0.65 (-0.15%)
At close: Jul 31, 2026
Cohance Lifesciences Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Cohance Lifesciences stock has a consensus rating of "Hold" and an average price target of ₹514.00. The average 1-year stock price forecast is 20.93% higher than the current stock price, while the lowest is ₹300.00 (-29.42%) and the highest is ₹1,150 (+170.56%).
Price Target: ₹514.00 (+20.93%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Cohance Lifesciences stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 4 | 4 | 4 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 2 | 3 | 3 | 1 | 1 | 1 |
| Sell | 1 | 0 | 0 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 2 | 2 | 2 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Financial Forecast
Revenue This Year
26.13B
from 22.69B
Increased by 15.18%
Revenue Next Year
30.88B
from 26.13B
Increased by 18.18%
EPS This Year
7.17
from 5.24
Increased by 36.79%
EPS Next Year
10.22
from 7.17
Increased by 42.58%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.